You Position: Home > Paper
Progress in the development of crystallized proteins as drug delivery system
( views:35, downloads:0 )
- Author:
- No author available
- Journal Title:
- ACTA PHARMACEUTICA SINICA
- Issue:
- 8
- DOI:
- 10.3321/j.issn:0513-4870.2009.08.004
- Key Word:
- 蛋白质;结晶化;传递系统;蛋白稳定性;缓释制剂
Abstract： 结晶化作为一种改善药物稳定性和疗效的有效途径而广泛应用于制药领域,但蛋白质晶体由于复杂的结晶行为限制了其在药物传递系统中的广泛应用.随着蛋白质结晶技术的不断发展及其工业化应用,蛋白质晶体作为一种新型的生物大分子给药系统日益受到关注.热力学稳定的晶体结构可提高蛋白质类药物的理化稳定性,并具有缓释性能.本文根据近年文献报道,介绍了蛋白质晶体作为药物传递系统的研究现状和进展,并系统阐述了蛋白质结晶的基本过程、制备方法及应用特点.
- [1]Jian, Qiu,Xiao-hui, Wei,Fang, Geng,etc.Multivesicular liposome formulations for the sustained delivery of interferon alpha-2b.[J].2005,26(11).
- [2]Higbie A,Qu S,Pechenov S,etc.Novel long-acting crystal formulation of human growth hormone.[J].2005,22(9).
- [3]Schulze-Briese C,Schluckebier G,Wagner A,etc.Crystal structure of ultralente--a microcrystalline insulin suspension.[J].2009,74(4).
- [4]V R, Sinha,Aman, Trehan.Biodegradable microspheres for protein delivery.[J].2003,90(3).
- [5]Simi CK,Emilia-Abraham T.Encapsulation of crosslinked subtilisin microcrystals in hydrogel beads for controlled release applications.[J].2007,32(1).
- [6]Gallagher DT,Tung M.The Biomolecular Crystallization Database Version 4: expanded content and new features.[J].2009,65(Pt.1).
- [7]N E, Chayen.Comparative studies of protein crystallization by vapour-diffusion and microbatch techniques.[J].1998,54(Pt 1).
- [8]Lai MC,Topp EM.Solid-state chemical stability of proteins and peptides.[J].1999,88(5).
- [9]Lye Gary J.,Lee Timothy S.,Vaghjiani Jeetendra.A systematic approach to the large-scale production of protein crystals[J].2000,26(8).
- [10]Margolin AL,Jacob LD,Shenoy B,etc.Cross-linked protein crystals for vaccine delivery.[J].1999,96(17).
- [11]McPherson A.Introduction to protein crystallization.[J].2004,34(3).
- [12]Astaneh R,Erfan M,Nafissi-Varcheh N.Zinc-leuprolide complex: preparation, physicochemical characterization and release behaviour from in situ forming implant[J].2007,13(10).
- [13]M, Frey.Water structure associated with proteins and its role in crystallization.[J].1994,50.
- [14]Vadim, Klyushnichenko.Protein crystallization: from HTS to kilogram-scale.[J].2003,6(6).
- [15]Yang MX,Margolin AL,McGrath M,etc.Crystalline monoclonal antibodies for subcutaneous delivery.[J].2003,100(12).
- [16]Chernov AA..Protein crystals and their growth[J].2003,142(1).
- [17]Kwon JH,Lee JJ,Kim CW,etc.Insulin microcrystal suspension as a long-acting formulation for pulmonary delivery.[J].2004,22(2).
- [18]Merkle HP,Jen A.Diamonds in the rough: protein crystals from a formulation perspective.[J].2001,18(11).
- [19]S. P. Meeker,W. C. K. Poon,P. N. Pusey.Concentration dependence of the low-shear viscosity of suspensions of hard-sphere colloids[J].1997,55(5).
- [20]Valge-Archer VE,Reichert JM.Development trends for monoclonal antibody cancer therapeutics.[J].2007,6(5).